We are excited to announce that our abstract titled “Performance characteristics of a novel, fully automated immunoassay microarray for the qualitative serological detection of specific IgE directed against Bet v 1” has been accepted by the European Congress of Immunology (ECI 2024), a major international event on immunology, to be held in Dublin, Ireland, from 1 to 4 September 2024. Accepted abstracts will be published in the European Journal of Immunology.
The abstract, which is AliveDx’s first scientific communication in the Allergy segment, showed positive results in analytical comparison and precision evaluations, demonstrating the assay’s robustness.
